Lenvatinib Mesylate and Valproate Injection
Determining the interaction of Lenvatinib Mesylate and Valproate Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: valproic acid
Brand name: Depakene, Depacon, Stavzor, Valproate Sodium
Synonyms: Valproic acid, Valproic Acid and Derivatives
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Valproate sodium Intravenous
- Lenvatinib Mesylate-Valproic acid
- Lenvatinib Mesylate-Valproic Acid and Derivatives
- Lenvatinib Mesylate-Valproic Acid Capsules
- Lenvatinib Mesylate-Valproic Acid Liquid
- Lenvatinib Mesylate-Valproic Acid Oral Solution
- Valproate Injection-Lenvima
- Valproate Injection-Lenvima (14 MG Daily Dose)
- Valproate Injection-Lenvima (18 MG Daily Dose)
- Valproate Injection-Lenvima (20 MG Daily Dose)
- Valproate Injection-Lenvima (24 MG Daily Dose)
- Valproate Injection-Lenvima (8 MG Daily Dose)